Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine crossover study of driving performance and ERPs in adults with ADHD
2007-001855-20Phase 4Active
- Sponsor
- Utrecht University
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of atomoxetine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Utrecht University. Primary endpoints: Driving performance, Attention-related event-related potentials during driving and 1 more. Started Jun 2008; status: active.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2007-001855-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001855-20.